Caffeic Acid Tablets: A New Choice For Hemostasis And Leukocyte Elevation In Multi-specialty Applications
Caffeic Acid tablets, as a drug with the functions of hemostasis and leukocyte elevation, have…
News
Tired of Chronic Pain? Aprocitentan Challenges: Is It Time to Try Something Different?
Tryvio (aprocitentan) is a novel antihypertensive medication developed by Idorsia Pharmaceuticals. Approved by the U.S.…
Could Zelsuvmi Be The Answer To Skin Cancer?
What Is Zelsuvmi Used For? ZELSUVMI™ (berdazimer) is a first-in-class topical medication that was approved…
Is Rezdiffra The Key To Unlocking Better NASH Outcomes?
In March 2024, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Rezdiffra…
Chemo Failed? Tislelizumab-jsgr Offers a Second Chance for ESCC Patients
Tevimbra, known generically as tislelizumab-jsgr, is a humanized IgG4 monoclonal antibody developed by BeiGene. It…
FDA Approved Qfitlia: Discover A Novel Hemophilia Treatment
Phil GattonePresident and CEO, National Bleeding Disorders Foundation“…. Qfitlia takes a novel approach to providing…
Is LetibotulinumtoxinA-wlbg the Perfect Answer to Glabellar Lines?
Letybo(letibotulinumtoxinA-wlbg), developed by South Korean biopharmaceutical company Hugel, has recently received FDA approval for the…
How Much Do You Know About Niktimvo’s Healing Properties?
Niktimvo (axatilimab-csfr) is a prescription medicine used to treat chronic graft-versus-host disease (cGVHD) if you have received at…
Zevra Therapeutics’ Miplyffa Receives FDA Approval To Fill NPC Treatment Gap
In a key step forward in the field of rare disease treatment, the U.S. Food…
Why Lazcluze Is The Nemesis In The Treatment Of Non-Small Cell Lung Cancer？
Lazcluze is a cancer medicine used to treat adults with advanced non-small cell lung cancer…
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights